Monthly Archives: दिसम्बर 2007

ग्रिप हील का शवास संबधित वाइरस पर असर -एक रिपोर्ट (In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses.)

हाँलाकि यह खबर शायद क्लासिकल होम्योपैथिक चिकित्सकों को रास न आये 🙂 लेकिन Gripp Heel नाम का यह ब्रांड जो फ़िलहाल अपने देश मे नही उपलब्ध है , इसका असर श्वास  से संबधित कुछ वाइरस पर देखा गया  हैं । देखें पूरी रिपोर्ट :


Gripp-Heel(R) is a homeopathic preparation frequently used in the treatment of respiratory viral infections such as various types of influenza and the common cold.

Plant pharmacological group:Aconitum napellus 4X (hoarseness; dry croupy cough), Bryonia alba 4X (dry mucous membranes; all symptoms worse with motion), Eupatorium perfoliatum 3X (hoarseness and cough; chest soreness)
Mineral pharmacological group:
Phosphorus 5X (painful larynx; breathing quickened)
Immunonodulator group:
Lachesis mutus 12X (left-sided sore throat)

The antiviral activity of Gripp-Heel was studied in vitro on human pathogenic enveloped and nonenveloped RNA and DNA viruses. Before the antiviral assays, in vitro cytotoxicity of Gripp-Heel was determined with cells used for the infection experiments (HeLa, HEp-2, MDCK, BGM) as well as with mitogen-stimulated peripheral blood mononuclear leukocytes. A concentration of 0.5 of the commercially available product slightly reduced cell viability and proliferative capacity, and experiments on antiviral activity were determined starting with a dilution of 0.2 of the commercially available product. The antiviral activity was determined against a broad panel of enveloped and nonenveloped DNA and RNA viruses with plaque reduction assay, cytopathogenic assays, virus titrations, analysis of the viral proteins in virus-specific enzyme immunoassays, and haemagglutination tests. Control substances were acyclovir (10 mug/mL), ribavirin (6 mug/mL), and amantadine hydrochloride (5 mug/mL), depending on the virus type. Gripp-Heel demonstrated dose-dependent in vitro activity (significant reductions of infectivity by 20% to 40%) against Human herpesvirus 1, Human adenovirus C serotype 5, Influenza A virus, Human respiratory syncytial virus, Human parainfluenza virus 3, Human rhinovirus B serotype 14, and Human coxsackievirus serotype A9. The mechanisms of this antiviral activity are still unclear, but type I interferon induction might be a possible explanation. Further research on this homeopathic preparation seems warranted.

 साभार  : Sue Young , Ncbi

थैलेसिमिया के रोगियों में होम्योपैथिक औषधियों की सफ़ल भूमिका – ( a preliminary study of the additional benefits to Thalassemic Patients on Hydroxyurea Therapy through homeopathy )



 थैलेसिमिया के रोगियों मे होम्योपैथिक औषधियों की भूमिका पर प्रकाश डालता हुआ यह शोध पत्र थैलेसिमिया के रोगियों मे एक नयी  रोशनी दे सकता है । ३८ रोगियों मे जिनमे  पहले से ही हाइड्रोक्सी-यूरिया लेने के बावजूद लाभ दिखाई नही दे रहा था , उनमे होम्योपैथिक औषधियाँ पल्साटिला ३० , फ़ेरम मेटिलकम ३० और सियोनेथस ३० या ६ को होम्योपैथिक सिद्द्दातं  ( similia similibus curentur ) के अनुसार दिया गया और परिणाम सार्थक दिखे ।

साभार : Oxford journal , The CAM Report

Can Homeopathy Bring Additional Benefits to Thalassemic
Patients on Hydroxyurea Therapy? Encouraging Results of
a Preliminary Study

Antara Banerjee1, Sudipa Basu Chakrabarty2, Susanta Roy Karmakar1,
Amit Chakrabarty2, Surjyo Jyoti Biswas1, Saiful Haque1, Debarsi Das1, Saili Paul1,
Biswapati Mandal3, Boujedaini Naoual4, Philippe Belon4 and
Anisur Rahman Khuda-Bukhsh1

1Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani-741 235,
2Institute of Genetic Engineering, 30 Thakurhat Road, Badu, Kolkata-700 128, 3Directorate of Research, Bidhan
Chandra Krishi Viswavidyalaya, Kalyani, West Bengal, India and 4Boiron Laboratory, 20 Rue de la Liberation,
Sainte-Foy-Les-Lyon, France

Source : Oxford journal , The CAM Report


The researchers say yes, particularly in the developing world where blood transfusions suffer from inadequate screening and fall short of the stringent safety standards followed in the developed countries.

First, the details.

  • 38 thalassemic patients received hydroxyurea therapy for a varying periods. Several homeopathic remedies, namely, Pulsatilla Nigricans (30th potency), Ceanothus
    Americanus (both mother tincture and 6th potency) and Ferrum Metallicum (30th potency)
    selected as per similia principles were administered to 38 thalassemic patients receiving
    Hydroxyurea (HU) therapy for a varying period of time.
  • The patients were studied before and after treatment. Levels of serum ferritin (SF), fetal
    hemoglobin (HbF), hemoglobin (Hb), platelet count (PC), mean corpuscular volume (MCV),
    mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH),
    white blood cell (WBC) count, bilirubin content, alanine amino transferase (ALT), aspartate
    amino transferase (AST) and serum total protein content of patients were determined before
    and 3 months after administration of the homeopathic remedies in combination with HU to
    evaluate additional benefits, if any, derived by the homeopathic remedies, by comparing the
    data with those of 38 subjects receiving only HU therapy.

And, the results.

  • There was a significant decrease in the ferritin blood levels (a complex that stores iron for use in metabolism) and an increase in fetal hemoglobin levels (oxygen-carrying pigment of red blood cells) during combined treatments.
  • Changes in other lab values were not significant.
  • There was a significant decrease in size of spleen in most patients with enlarged spleens.
  • General health improved and there was an increase in the time between transfusions in most patients receiving the combined homeopathic treatment.

The bottom line?
The authors concluded, “Homeopathic remedies being inexpensive and without any known side-effects seem to have great potentials in bringing additional benefits to thalassemic patients.”

सिमिलीमम -एक या अनेक ( Can it be possible to select more than one similimum )

नवम्बर 2007 के Hpathy .com पर जरमी शैएर का एक साक्षत्कार छपा है , विषय मनीष भाटिया ने उठाया है कि क्या जटिल रोगों ( chronic cases ) एक ही सिमिलीमम काफ़ी है या इससे भी अधिक सिमिलीमम हो सकते हैं . मुझे याद है कि कुछ दिन पहले डां प्रतीश पटेल ने भी यह प्रशन आरकुट मे एक कम्यूनिटी मे एक पोल के जरिये से उठाया था । होम्योपैथी मे औषधियों के स्त्रोत कई जगह से आते हैं जैसे वनस्पति ( plant kingdon) , जन्तु ( animal kingdon ), रसायनिक स्त्रोत ( minerals & chemicals), सारकोडस (sarcodes) और नोसोडस (nosodes) | इसके अलावा impondrebalia  ग्रुप जैसे x-ray इत्यादि। इतने व्यापक समूह से आने वाली औषधियों मे से अगर यह कहें कि इतने बडे ग्रुप मे सिर्फ़ एक ही सिमिलीमम हो सकता है तो यह अन्य होम्योपैथिक औषधियों के साथ नाइन्साफ़ी होगी । लेकिन स्वयं हैनिमैन ऐसा नही मानते , उनके अनुसार सही रुप से चयनित की गई  औषधि का दूसरा कोई विकल्प नही है । आपके अनुसार :

§ 119

HAHNEMANNAs certainly as every species of plant differs in its external form, mode of life and growth, in its taste and smell from every other species and genus of plant, as certainly as every mineral and salt differs from all others, in its external as well as its internal physical and chemical properties (which alone should have sufficed to prevent any confounding of one with another), so certainly do they all differ and diverge among themselves in their pathogenetic – consequently also in their therapeutic – effects.1 Each of these substances produces alterations in the health of human beings in a peculiar, different, yet determinate manner, so as to preclude the possibility of confounding one with another.2

1 Anyone who has a thorough knowledge of, and can appreciate the remarkable difference of, effects on the health of man of every single substance from those of every other, will readily perceive that among them there can be, in a medical point of view, no equivalent remedies whatever, no surrogates. Only those who do not know the pure, positive effects of the different medicines can be so foolish as to try to persuade us that one can serve in the stead of the other, and can in the same disease prove just as serviceable as the other. Thus do ignorant children confound the most essential different things, because they scarcely know their external appearances, far less their real value, their true importance and their very dissimilar inherent properties.

लेकिन जरमी शेऐर कुछ और ही सोचते हैं । जरमी पिछले २५ सालों से होम्योपैथिक के अध्यापन से जुडे हैं ।

jeremy_sherr.jpgI have a lot to say about this. Your observation is very correct. If homeopathy worked only by one simillimum, there would be no homeopathy. We would all be out of business. Even if it worked with only five remedies for a patient, we would still be out of business. After 25 years of teaching and presenting cases, I know that in a class of twenty students you can get fifteen different suggestions for a case. Then the teacher says that I gave this particular remedy and the whole class thinks, �Oh! I am wrong because the remedy mentioned worked and the teacher must be right�. And therefore it propagates this thing about the simillimum. I think that quite a big range of remedies can work for each patient. I have traveled across the world and have seen how different homeopaths give different remedies and get results. Like you said, everybody is successful to some degree. This is so important. For instance, if in a class, your suggestion is different from the teachers, you should not lose confidence and think that he was right and you were wrong. It could be that your suggestion is right as well. That is one ramification of it.

The next ramification of it is that building up materia medica from cases is very secondary, of much less importance than provings. Because you can say that you saw three or four cases of a certain remedy, but in those cases the remedy could really be just a similar or partially similar. Then you are including all the data from these partial cases into the essence of the remedy, but I don�t think that all the data necessarily belongs to that remedy. Even if you give a partially similar remedy it has the power to sweep away many symptoms in the case that do not belong to the remedy. To know whether a remedy is the simillimum or not, there is a very strict criterion. For instance Kent gave the definition that if you give the simillimum, then there should be an aggravation of the existing symptoms, then the symptoms should get better and then there should be a relapse of the original symptoms.

So now let�s look back at what Hahnemann has said. Hahnemann definitely said that there is no such thing as the simillimum. He said that the simillimum is a theoretical concept. In Paragraph 156, he says you can not fit a remedy to a case like two triangles with equal angles and equal sides. This will not happen. There can not be �a� simillimum. Because by definition if you say �this simillimum�, there could be only one remedy that will work for the case. But if you give Pulsatilla nigricans, maybe Pulsatilla nutalliana could be more similar, or maybe Pulsatilla from some other continent would be better, or perhaps a spider remedy we don�t know.� All these remedies could help to different degrees, but logically you can never tell if there is a better remedy round the corner.

Remedies are like poems. Some touch you more and some less, but you can never say that there is one ultimate poem to touch a person, there might always be a better one.